跳至主要内容
临床试验/PACTR201409000702188
PACTR201409000702188已完成未知

Monitoring Artemether-Lumefantrin (ALU) and Artesunate-Amodiaquin (AS-AQ) efficacy in uncomplicated malaria treatment in Bandiagara, and Doneguebougou¿s area, Mali.

WANETAM/MRTC/DEAP/FMOS/USTTB0 个研究点目标入组 320 人开始时间: 2013年11月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Year(s) 至 70 Year(s)(—)
性别
All

入选标准

  • age between 6 months-70 years;
  • -résident in Bandiagara and area of Donéguébougou during study follow up periode ;
  • -Be able to take tablet per os
  • -Body temperature ¿ 37,5 degree Celsius or history of fievre within last 24 hours;
  • -Plasmodium falciparum infection parasitemia between 2000 et 200 000 asexual forms/ul associated or not with P. ovale, P. malaria and/or P. vivax ;
  • -consent of participant or/and parent (ou guardian) for children

排除标准

  • Clinical signs of severe malaria or cerebral malaria according to WHO criteria
  • - Patients with severe concomitant disease
  • - Concomitant febrile disorders (otitis, Acute chest infection, tonsillitis and others)
  • - Have a lower than 8 g / dl hemoglobin;
  • - Known to be allergic to artemisinin derivatives;
  • - Have a documented decision CTA in the last fifteen (15) days.

研究者

发起方
WANETAM/MRTC/DEAP/FMOS/USTTB

相似试验